Cardiovascular Flashcards

(255 cards)

1
Q

Functions of AT2 receptor?

A

Vasodilation, natriuresis, antigrowth factor, anti fibrosis, tissue regeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Functions of AT1 receptor?

A

Vasoconstriction, increased PVR, increased Na resorption, increased aldosterone and increased Na resorption in collecting ducts, increased vascular growth factors, atherogenesis, increased ADH, thirst, CO, decrease GFR, cardiac hypertrophy, fibrosis, ROS, inflamm cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sex bias in dogs for hypertension?

A

Males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cats age and hypertension?

A

Increases with increasing age and with increasing HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CKD and hypertension in cats?

A

20 - 60 %, 65 - 100 % of hypertensive cats with TOD have evidence renal dysfunction.

No corr with severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophys hypertension renal dz?

A
RAAS 
Symp tone
Na retention
Excess free water
Structural arterial changes and endothelial dysfunction,. lack of local NO, increased ET
Ox stress/ROS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SDMA and BP?

A

? assoc with NO?

ADMA no corr with hypertension or TOD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What types of CKD more likely have hypertension dogs?

A

Glomerular

60 % of glomerular dz secondary to leishmania

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T/F: cats with polycystic kidney disease have high BP?

A

False, not common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Evidence for antihypertensives in cats?

A

60 % cats with SHT reached 15 % decrease or less than 150 BP using amlodipine, cf 18 % placebo

Decreased clin manifestations too but no imp survival

May decrease aldosterone secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T/F: amlodipine is really excreted?

A

No - hepatic metab, no need to drop dose in renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What glomerular arteriole does amlodipine preferentially dilate?

A

Afferent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amlodipine and antifungals?

A

Azoles might decrease metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When to use emergent BP management?

A

TOD and > 180

> 200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MAP calculation?

A

Diastolic + (systolic - diastolic)/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neural control of vascular tone?

A

Vasomotor centre, medulla oblongata, constrict tissue bed dilate muscle with sympathetic stim

Baroreceptors in carotid body and aortic arch lack of stretch
Atria and pulm artery lack of distension (stretch receptors)

Also hypoxaemia/hypercarbia via chemoreceptors carotid body and aortic arch

Also effects macula densa to decrease GFR and conserve sodium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Mechanism of hypotension in sepsis/SIRS?

A

NO production
Depletion vasopressin
Disrupted smooth muscle calcium
Downregulation catecholamine receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How much hypovolaemia to cause hypotension?

A

20 - 25 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cardiac effects of SNS activation?

A

Increased SA node firing
Beta adrenergic receptor activation - increase slow inward calcium current so increase SA node firing
Shift activation curve inward pacemaker current (If), more pos voltage, Gs adenyl cyclase

Adrenergic activity increases contractility - beta - SERCA2, ryanodine, L type calcium channels, phospholamban

Augmented calcium induced calcium release and reuptake into SR

PKA force and contraction myofilaments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Effect of cardiac disease on CO at increased HR?

A

CO drops off at lower HR than healthy

NB downreg/uncoupling (beta arrestin, beta receptor kinase) beta1 receptors in heart failure, diminished contractility
Depletion cardiac norepinephrine stores, reply on systemic

Decreased response to adrenergic stim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why can’t peripheral nerves produce epinephrine?

A

No phenylethanolamine N methyltransferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Catecholamines in heart failure?

A

NE and epi higher than controls for both DCM and valve dz, NE maybe higher in DCM, corr with severity

Cats - both increased in cardiac dz also cong and noncong

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Heart disease SNS or RAAS 1st?

A

SNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Stim for renin?

A

SNS beta 1 activation juxtaglomerular cells
Decreased renal perfusion
Decreased sodium absorption PCT

ATII inhibits renin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
ATII remodelling?
MAPK NB activation chymase myocardium ATIII less potent ROS (ATII and aldosterone) myocardial hypertrophy
26
Where do the natriuretic peptides come from? Effects?
BNP ANP atria CNP endothelium More BNP in chronic cardiac as ventricles start to make Counteract RAAS. A type natriuretic peptide receptor. Induce natriuresis/diuresis. Inhibit tubular sodium transit inner medullary collecting duct. Vasorelaxation Inhibit renin and aldosterone release NPRB does vasodilation from CNP (local) NPRC clears the natriuretic peptides from circulation (ANP > BNP) N terminal fragments of pro forms renal excretion so longer
27
Use of BNP in diagnostics?
Cats - marked increase BNP in myocardial dz More useful than ET1
28
What is conivaptan?
V1A/V2 blocker Normalise sodium and help congestion Tolavaptan = V2 specific AVP increased in heart failure
29
What factors cause vasoconstriction when CO falls?
Norepi, vasopressin, ET, ATII - calcium mediated vasoconstriction (muscle hypertrophy when chronic)
30
What causes endothelin release?
Hypoxaemia, stretch, ATII AVP NE bradykinin Growth factors cytokines tGFbeta
31
ET1 and NO?
ET 1 increases NO which then decreases ET1
32
When is ET1 increased?
Cardiac dz pulm hypertension renal disease not systemic hypertension
33
Cardiac remodelling?
Physiological reversible pathologic not. Hypertrophy from increased wall stress, wall stress normalised by hypertrophy (compensation), exhaustion and death of cardiomyocytes, fibrosis, ventricular dilation, decreased CO Fibroblast proliferation AT11 aldosterone
34
Law of Laplace?
Wall stress = pressure x radius/2x wall thickness Pressure overload - compensate with increased wall thickness, still increased energy requiremenet Volume overload - modest wall thickness inc with chamber enlargement - appropriate workload redistribution, less increase in total work Concentric hypertrophy - parallel sarcomere replication
35
Most common cause of death aortic stenosis?
Sudden death vent arrhyth (hypoxia?)
36
Terminal concentric hypertrophy?
Initial decrease collagen breakdown (metalloproteinase inhibitor decrease MMP 1 and 9( Then collagen breakdown increases and hypertrophied ventricle dilates and fails
37
When is pleural effusion in heart failure most likely?
Biventricular due to overload of lymphatic drainage
38
What nitrate vasodilators effect pre and afterload?
Nitroglycerin preload - venodilator, nb tachyphylaxis | Nitroprusside balanced vasodilator
39
ACEi in CHF?
No prospective evidence preclinical MVD, retrospective DCM though benazepril improved outcome Use in chronic diuretic
40
Dobutamine mechanism of action?
Beta1 antagonist - inotrope and lusitrope
41
Beta blockers in feline myocardial disease?
Detrimental heart failure, neutral preclinical Dog - detrimental heart failure
42
What is atropine used to predict?
Medical management for sick sinus syndrome, doesn't predict well with AV block
43
What factors determine the impact of arrhythmia on animal?
``` Rate Length sustained for Atrial ventricular temporal assoc Sequence of ventricular activation Myocardial/valvular function Cycle length irregularity Drug therapy Extra cardiac influences ```
44
What causes wide QRS?
Macro reentry BBB Ventricular premature complex Eg asynchronous ventricular depolarisation T wave should also be abnormal
45
What does vagal predominance do to ECG?
Wandering pacemaker - increased P w/ increased HR on insp Sinus arrhythmia
46
What is ventriculophasic sinus arrhythmia?
P-P interval longer during AV block cf surrounding - P-P interval flanking QRS (2nd or 3rd degree)
47
Differentiate wandering pacemaker or sinus arrhyth from atrial arrythmia?
HR < 150 P's taller not narrower Degree of prematurity
48
Criteria for APC?
``` Premature timing Normal QRS (v occasionally wide/absent if timing dose to repol of ventricle) Non compensatory pause Diff amplitude P Diff P-R interval ``` Often structural. Also HT4 digitalis atrial tumour. Atrial tachycardia = three or more APC > sinus rate (160/220)
49
Criteria for atrial flutter?
Flutter waves (rhythmic monomorphic) Lack fo return to baseline Normal QRS Variable R-R Macroreentrant Treat if many passing AV node (tachycardia mediated cardiomyopathy > 240 > 3w)
50
Atrial fibrillation?
15 % canine arrhythmias, present in 50 % DCM Electrical disorganisation at atrial level Chaotic fibrillation waves Irregular R-R No P waves Normal QRS
51
Afib prognostic importance?
Cause impacts rate - lone then subclin then CHF Lone better px Afib worsen prognosis large dogs with MMVD and CHF
52
How to treat AFib?
Digoxin and diltiazem, change dose of latter, aim 130 - 145, ECG assessment Better HR control together cf alone Beta blockers inferior Treatment improves survival time in CHF large breed MMVD dogs if add digoxin cf diltiazem alone Conversion - defib, amiodarone, lidocaine
53
Atrial dissociation?
Larger P wave passes AV other one stays in atrium - no significance
54
VPC criteria?
Most common pathological rhythm disturbance Wide QRS, different with different T and no P Narrow R-R interval ``` Diagnostic of VT: Fusion beat (normal and premature collide) Capture beat (normal PQRST after VPCs) ``` Usually compensatory pause or interpolation > 3 in a row vtach ``` Must differentiate from: Escape complexes Potassium disturbance Cardiomegaly Bundle branch block Motion ``` More commonly cardiac in cats than dogs NB inherited sudden cardiac death GSD - myocardial depolarisation defect
55
Cut offs for ventricular arrhythmias?
< 70 idioventricular, < 160 accelerated idioventricular, > 160 vtach
56
What should accompany ventricular fibrillation?
Unconscious, no pulses
57
What is Torsades de Pointes?
Ventricular arrythmia, arises from Q-T interval prolongation Rotation of peaks due to changing geometry of reentrant circuit Diagnosis: Slow rhythm with prolonged QT before R on T extrasystole (R occurs during vulnerable T wave) Rapid ventricular rhythm with QRS complexes more regular than VF but with changing amplitude and polarity Causes: Hypokalaemia and hypocalcaemia Congenital long QT syndrome of dalmatians Class 1A antiarrthythmics eg quinidine Tx - magnesium
58
Describe AV blocks
1st degree: long PR interval - high vagal tone/digitalis/alpha2 2nd degree: complete transient AV conduction interruption. Mobitz I - progressive lengthening, Wenckeback phenomenon. High AV node good prognosis. Rare clin signs. II - sudden, more guarded/poor px (?). Essentially if high grade same as 3rd degree and need pacing. 3rd degree: complete sustained with escape rhythm. Can be incidental 110 - 140 bpm cats, can be subclin, but most likely of the 3 to cause clin signs Sometimes caused by atrial dilation 2/3 can be functional alpha 2 hyperkalaemia digitalis but more common structural age inflamm or degen Low number 3rd degree resolve or convert to second degree spontaneously
59
Treatment of AV block?
Pacing high degree 2nd II/3rd degree, increase survival cf no pacing
60
Feline AV block?
More than half have cardiomyopathy, in general have long survival times with no pacing as incidental
61
What are bundle branch blocks?
Altered bundle of his conduction - not arrhythmias in and of themselves Wide QRS due to ventricular desynchronisation Duration QRS > 0.07 dog or > 0.04 cat Lead II - polarity pos left neg right Hypertrophy, dilation, inflammation Right - no issue Left - indicative of left ventricular enlargement
62
What block do cats with heart disease get?
Left anterior fascicle block- degeneration/fibrosis/osseous metaplasia of left bundles more common than right Tall R wave lead 1 Deep S wave II and III Left axis deviation
63
What causes atrial standstill?
Hyperkalaemia Atrial myopathy eg marked stretch ECG artifact
64
Cardiac effects of hypokalaemia?
Cardiomyocytes more negative and AP longer (prolonged repolarisation) therefore near threshold longer - proarrhythmic Latter effect clinically dominates < 3.5 Prolonged QT, atrial dissoc Class I antiarrhythmics eg lidocaine act on sodium channels which require K to function, so hypokal can cause refractoriness to antiarrhythmics
65
Cardiac effects of hyperkalaemia?
Increased membrane potassium permeability during depolarisation when mild - rhythm stabilising, this predominates over depolarising effects (makes cell more pos overall) Mild - short Q-T, narrow tall T wave (only 15 % for latter) Decrease activity normal pacemaker tissue/decrease slope phase 4 depolarisation - sinus bradycardia, however HR unreliable Wide QRS and decreased R wave amplitude - interfere cell-cell transmission velocity in ventricles P-R prolongation, absence of P waves Atria more sensitive than ventricles, myocardium most in atria, - sinoventricular rhythm (don't see P but SA is firing)
66
Cardiac effects of hypocalcaemia?
Alter myocyte AP threshold, not resting potential. Low decrease threshold and facilitate depol. This is most in skeletal muscle minimal in cardiac. Prolongs initial ventricular depolarisation - prolong QT
67
Why is calcium cardio protective?
Potassium raise resting membrane potential, calcium raise depolarisation threshold - so more normal gradient
68
What should be monitored during calcium infusion?
Shortened QT, ventricular complexes, decrease HR Calcium raises depol threshold and shortens ventricular repol
69
What is an orthodromic AV reentrant tachycardia?
Normograde transmission AV node retrograde through accessory - macroreentrant loop - WolffParkinsonWhite
70
Diagnosis of sick sinus syndrome?
Prolonged sinus pauses, 1st/2nd degree AV block, bursts of supra ventricular tachycardia/ventricular asystoles - get ECG during episode of syncope/stumbling etc - episodes occur during bradycardia Atropine response predict response to medical management - eg theophylline controls 50 % Sometimes only sinus bradycardia
71
Criteria to institute pacing?
High degree second or any third degree AV block | SSS/SND with clin signs HR < 50, sinus pauses >3s when awake
72
What congenital cardiac defect do Chartreux cats get?
ASD and TVD
73
Siamese?
Supravalvular mitral stenosis, endocardial fibroelastosis
74
Most common congenital cardiac dz cat/dog?
Dog - PDA, AS, PS | Cat - VSD, PDA, TVD, MVD
75
What congenital conditions can severity be predicted from murmur duration and intensity?
SAS, PS
76
Lesions in Eisenmenger's syndrome?
R to L shunt Pulmonary arterial intimal thickening, medial hypertrophy, plexiform lesions +/- pulm vasoconstriction
77
Embryology of PDA?
Embryonic left sixth aortic arch Should close 7 - 10 d Only elastic no muscular fibres in ductal media Tapering most common, non tapering more severe and uncommon (the latter assoc with pulm hypertension and r-l or bidirectional shunting
78
Name 3 breeds common PDA?
GSD, Lab, cocker also poodle, bichon female!
79
Ddx for continuous murmur?
PDA, aortopulm shunt, coronary AV fistula
80
ECG with right ventricular hypertrophy?
Right axis deviation, deep S wave
81
Difference cat PDA?
More common pulm hypertension development
82
What PDAs not amenable to amplatz?
Non tapering - type III
83
Genetic VSD?
Keeshond
84
Breeds ASD?
Boxer, Samoyed, Doberman Chartreux, Persian
85
Breeds VSD?
English bulldog, WHWT, ESS Maine coone
86
ECG VSD?
Notched/wide Q
87
TVD breeds?
Labrador - autosomal dominant mutation with incomplete penetrance Gret, Gt Dane, GSD male!
88
Mitral valve stenosis?
Bull terrier
89
Mitral valve dysplasia?
GSD, Get, Gt Dane
90
ECG TVD?
Splintered QRS
91
Pulmonic stenosis breeds?
Beagle, cocker, Lab Supravalvular - giant schnauzer Subvalvular - boxer and English bulldog, anomalous corony artery development - circles RVOT below pulmonic valve
92
Cause of pulmonic stenosis?
Subvalvular/valvular obstruction or valve dysplasia Thickening, leaflet fusion, annular hypoplasia, tethered valves Overproduction normal valve collagen
93
Pulmonic stenosis severity?
Mild < 50 Severe > 80 Mild/mod probably normal life Severe > 125 frequent major consequences
94
Criteria for pulmonic stenosis intervention?
Severe > 100 Symptomatic Tricuspid regurgitation Balloon - decrease pressure 50 % + in 80 % 50 % reduction mortality
95
Breeds for SAS?
Boxer, rottie, Bull terrier valvular Newfie - autosomal dominant, PICALM gene Dogue de Bordeaux auto recessive GRet Normal boxer aortic annulus is smaller cf other breeds
96
What other abnormality assoc with SAS?
Mitral valve lesions
97
SAS severity?
80 - 100 = mod can overest if CO high Mild around 2.3 - 2.4 m/s < 50 normal life > 125 severe consequence
98
SAS management?
``` Prophylactic ABs (though evidence?) Balloon - decrease severity 50 % but improvement attenuated over time, no sig diff survival cf atenolol ``` Beta blockers to decrease myocardial ischaemia, decrease HR, decrease myocardial o2 consumption, increase diastolic time However again no sig survival benefit atenolol
99
Breed for ToF?
Keeshond, English bulldog
100
Abnormalities ToF?
Transposed aorta, right ventricular hypertrophy, VSD, RV outflow obstruction
101
MMVD signalment?
CKCS, dachshund, mini poodle, yorkie Male > female Males develop younger than female
102
What happens if breed two MMVD early onset dogs?
Earlier onset dz in pups, and vice versa Gene loci 13 and 14 assoc with age of onset in CKCS
103
MMVD histopath?
Weakened/disturbed connective tissue, prominent spongiosa, disorganised collagen fibres iin fibrosa layer, increased mucopolysacharide/glycosaminoglycan, endothelial cells damaged esp edge
104
Pathophys MMVD?
Endothelial damage > ET1 > valvular interstitial cells become myofibroblast/smooth muscle cells (serotonin driven - increased in CKCS), MMPs
105
Which leaflet more likely to prolapse MMVD?
Anterior - more mobile, jet lesions laterally directed
106
MMVD heart chamber enlargement?
Initially slow, fast in 6-12 months before CHF
107
MMVD XR changes?
Elevation caudal trachea and left mainstream bronchus, bulge/straightening caudal border heart, bulge 2-3oclock XR pulm oedema - dorsocaudal, perihilar, often RHS worse - cranial can be first in acute
108
XR right heart enlargement?
Increased sternal contact, elevation trachea, straight cranial border, vena cava enlargement, bulge 9 - 12 - reverse D shape
109
How to measure LA?
Right parasternal short axis view
110
MMVD - why would regurgitant jet velocity be low?
Hypotension, myocardial failure, increased LA pressure, impending CHF
111
Risk factors MMVD progression?
Large breed, older, male, severity of valve lesion, severity MR/LA/LV dilation, HR, NTproBNP, troponin, arrythmia, syncope
112
Ddx for MMVD?
Endocarditis, DCM, congenital cardiac dz Endocarditis lesions more isolated and echogenic
113
Evidence for stage B MMVD tx?
ACEi mono therapy: no difference survival placebo control - SVEP/VETPROOF Beta blocker: experimental? prospective placebo control trial terminated due to lack of efficacy Amlodipine: ? imp echo? Pimobendan: decrease cardiac size. EPIC delays onset CHF (doubles time) in B2 (LVIDD > 1.7, LA:Ao > 1.6, VHS > 10.5)
114
Goals in management of stage C MMVD?
Reduce venous pressure Maintain CO reduce regurg and cardiac workload Protect heart from negative neurohormonal effects
115
Benefit of torasemide?
Longer duration of action, potency less affected by diuretic resistance, aldosterone antagonist properties
116
Evidence for stage C MMVD?
Pimobendan: VETSCOPE/QUEST - adjunct to diuretic, less severe CHF and longer survival cf ACEi + diuretic. Decrease HR, decrease free water retention, decrease heart size, decrease regurg. ACEi: less severe clin signs less exercise intolerance live longer. Counteract reflex RAAS stim when diuretics admin. Spironolactone: decrease cardiac death/euthanasia/worsening CHF when add to other tx Digoxin: weak pos inotrope, decrease baroreceptor reflex tachycardia/decrease central symp activity no evidence
117
Prognostic factors after onset CHF?
Pos: pimo, ACEi, Neg: higher furosemide dose, worsening exercise tolerance, cardiomegaly, worse MR, LVIDD, E wave velocity, worsening systolic function, decreasing creatinine (cachexia), complication development
118
What drugs might reduce MR/LA size?
Pimobendan, afterload reducers (amlodipine hydralazine ACEi), diuretic
119
Pulmonary hypertension in MMVD?
Pressure gradient > 55 neg prog factor
120
Endocarditis signalment?
Male middle age medium to large purebreed
121
Pathophys endocarditis?
Either direct bacterial contact or haematogenous (capillaries in valves) - bacteria usually req predisposing factors to colonise eg immune supp, endothelial damage/platelet-fibrin complex deposition - adhere to valve Extracellular matrix protein, thromboplastin and tissue factor trigger coagulation, coagulum forms, inflamm starts Inflamm and bacterial enzymes cause valve tissue degradation
122
Endocarditis bacteria?
Staph (aureus, pseudintermedius, coagulation pos and neg)/Strepp (canis, bovis, beta haemolytic). Ability to adhere to valves. Also - E coli, P aeruginosa, Corynebacterium Staph aureus and Bartonella (henselae, clarridgeiae, washoensis) internalise in endothelium, evade immune system and antibacterials Some no detectable infection elsewhere
123
Consequences of endocarditis - what factors?
Bacteria - virulence/production of endocrine or exotoxins (gram neg paracute/acute, chronic subacute/chronic) Site of infection and impact on valve function - necrosis/destruction of valve stroma/chordae tendinae peracute/acute with CHF Sequelae eg immune complex deposition, vegetative thrombi/metastatic infection - thromboembolic 30 - 40 %, lungs then kidneys most common, then distal aorta
124
Most common valves endocarditis?
Left heart, mitral > aorta, aortic more common Barttonella | Might involve wall (mural endocarditis) but rarely RHS
125
What is an intracardiac vegetation made of?
Platelets, WBC, fibrin, bacteria, RBC - often covered by intact endothelium
126
When to raise suspicion for endocarditis?
``` Immunosuppression Non-oral surgery within 3m Trauma to or infections of oral or genital mucosa Indwelling catheters Infected wounds Abscess Pyoderma ```
127
Most common clin sign endocarditis?
Lameness 34 %, new heart murmur (diastolic with bounding pulses = aorta - aortic insufficiency) Heart murmur 75 % Ventricular arrythmia 60 % aortic, arrthymia 50 - 75 % overall Fever 50 - 90 % (absence more common in aortic or Bartonella)
128
Endocarditis echo?
Hyperechoic, independent movement, irregular outline Erosive more difficult to identify - severe aortic regurg raise suspicion However congenital SAS/systemic hypertension could also cause this/myxomatous valve/quadricuspid aortic valve
129
Arrhythmias in endocarditis?
Ventricular most common | ST segment deviation (?myocardial hypoxia/embolism/ischaemia)
130
CHF in endocarditis?
50 % - perihilar/caudodorsal pulm oedema - no diff with valve affected LA enlargement not common (acute)
131
Blood culture endocarditis?
Negative in up to 60 - 70 % of cases - ABs, encapsulated infection, non-infectious endocarditis, Bartonella/slow growing organisms In positive cultures, 90 % pos in 72 h
132
Bartonella in endocarditis?
28 % of cases in Cali, 50 % of those with neg culture Also cause in cats Concurrent pos serology for tick borne dz common (tick/flea vector)
133
Criteria for canine endocarditis diagnosis?
Definitive: histopath of valve, 2 major, 1 major and 2 minor Possible - 1 major 1 minor, 3 minor Rejected - other disease, resolution valve abnormalities in 4d, no PM evidence Major - pos echo (vegetative/erosive/abscess), new valvular insufficiency (> mild aortic, no SAS/annuloaortic ectasia), pos culture (>1 pos or > 2 if common skin contaminant) Minor - fever, > 15 kg, thromboembolic or immune mediated disease, pos culture (other), pos bartonella serology > 1:1024
134
What should you not use alongside aminoglycosides?
Diuretic - potentiate nephrotoxicity
135
ABs for endocarditis?
Beta lactam and aminoglycoside (or enro but resistance poss) Depends on organ involvement Also seek source IV AB 1-2w, 6w overall, apt blood culture after 1-2w AB and 1-2w after. stop Repeat echo during and after too Monitor Bartonella with serology 1m after start AB - increased = ineffective, decreased = effective
136
Neg px endocarditis?
Late dx/late start tx Aortic Valvular vegetation Bartonella Gram neg Heart/renal complications not responding to tx Septic embolisation or metastatic infection Throbocytopenia, increased ALP or hypoalb (70 % mort with latter) Concurrent steroids Bacteriostatic AB/premature AB termination
137
Pos px endocarditis?
``` Mitral valve (MST > 400 d) G pos from skin/abscess/cellulitis/wound ```
138
When to use prophylactic AB to prevent endocarditis?
SAS PDA VSD - also make sure treat any infection aggressively Amoxi-clav/clindamycin NOT MMVD even if doing dental
139
Juvenile onset DCM?
Portuguese water dog (autosomal recessive chromosome 8, sudden death or CHF), toy Manchester terrier (sudden death) - < 1y
140
Forms of DCM?
Occult/overt (former murmur/echo/arrhythmia, latter coughing weakness etc)
141
DCM echo findings?
Decreased FS, ejection fraction, end. systolic diameter/volume Many also diastolic dysfunction No valve thickening Systolic dysfunction or ventricular dilation can occur first NB EPSS, sphericity index
142
Biomarkers for DCM?
ANP in dobermann's sig increased in occult and overt - other breeds not found sens/spec Troponin - increased doberman overt/occult, not sens/spec NTproBNP - increased in occult, quite sens, up to 1.5y pre-overt
143
Structural changes DCM?
Eccentric hypertrophy L > R Attenuated. waxy myofibrils, vacuolated myocytes, collagen fibres replace myocytes, fibrosis, necrosis, fatty infiltration
144
Specifics of cocker spaniel DCM?
ACS and ECS Taurine ACS - supp taurine/l-carnitine and increase FS/decrease LVIDD in 4m (not completely normal) - blood better than plasma. cont supp for life. often can discont cardio meds 3-4m when FS > 20 % ECS - familial? nutritional not identified. Marked LV enlargement. Variable dz course.
145
Dalmatian DCM?
Males Only left sided Arrhythmias uncommon Survival 1.5 - 30 m, no sudden death, refractory CHF Low protein diet? No evidence carnitind/taurine def. NB Dals occ get AV valve dz
146
Doberman DCM?
Left/bivent (left > right), Afib/sudden death Overt - Afb/VPC/CHF If syncope do holter - Brady and tachyarrhythmias Annual echo/holter = best predictors - increased LV end diastolic or systolic diameter; > 50 vpc/24h, couplets or triplets
147
Genetic mutations in DCM?
Doberman - autosomal dominant. PDK4 splice site mutation. Incomplete penetrance. Genetic test avail. not sole cause and this is only US NOT European. Great Dane - Xlinked Irish wolfhound - autosomal recessive, sex specific male dogs overrep Standard schnauzer - RNA binding motif protein 20 gene (RBM20), auto recessive, genetic test available
148
Great Dane DCM?
Weight loss/coughing. Ascites. Afib. Occ VPC. | Afib before echo changes.
149
Irish wolfhound DCM?
Males. Afib before structural. Precede CHF 24m. Sometimes VPC/LAFB Occ sudden death. More CHF (bivent, sometimes chylothorax) Low taurine?
150
Newfie DCM?
No gender predip. CHF, cough, bivent. V few have heart murmur. Afib most common.
151
Taurine in DCM?
Less likely in dog than cat as cats can't synthesise taurine dogs can. ACS taurine/carnitine Lamb meal/rice diet (rice bran/whole rice?) GRet - familial taurine deficiency Taurine blood < 150 plasma < 40 Supp might fix - reecho
152
Evidence for DCM meds?
ACEi: delay onset of CHF in doberman with ventricular dilation (retrospective) Beta blockers: 3m carvedilol no diff on anything Pimobendan: PROTECT study placebo control, support use in doberman in occult phase - survival benefit and delay CHF/sudden death. Also increase survival symptomatic.
153
Risk factor for cardiac death DCM?
Arrhythmias - rapid VT, complex ventricular, combination of vent arrhythmia, systolic dysfunction and chamber dilation - risk sudden death But sudden death occurs without these factors These are factors poss to treat arrhythmias - sotalol (beta blocker/potassium channel blocker) - dose cautiously if systolic dysfunction Mexilitene Amiodarone (cf neutropenia hepatic enzymes)
154
Negative prognostic indicators DCM?
Age of onset, pleural effusion, pulm oedema, ascites, AFib, end systolic vol index, ejection fraction, restrictive transmittal flow pattern
155
ARVC histopath?
Fibrous fatty infiltration RV wall, myocyte vacuolation and loss
156
Features of ARVC?
Boxer Vent arrhythmia/collapse/syncope/sudden death, some CHF (10 %, either left or bivent), some asymptomatic Small number systolic dysfunction and ventricular dilation Autosomal dominant inheritance with variable penetrance
157
Genetic cause ARVC?
Striatin gene mutation - genetic test available Homozygous severe - type III ARVC, structural heart disease variety and higher numbers of arrhythmias HOWEVER can have without the mutation
158
Type III ARVC?
Homozygous Systolic murmur/gallop, ventricular dilation/systolic dysfunction
159
What physiological murmurs do Boxers get?
Left basilar systolic (can also be aortic stenosis...) NOT indication of ARVC
160
Biomarkers for ARVC?
Troponin: increased, corr with VPC number and grade and arrythmia complexity BUT sensitivity lacking BNP not useful
161
ECG ARVC?
VPC single/pairs/paroxysmal runs Left bundle branch block morphology to VPC due to right ventricle affected > 100 VPC/24h or periods of couplets, triplets, runs VTach on holter considered suggestive, may have APC in vent dilation/systolic dysfunction
162
Echo ARVC?
Usually normal - might find right vent enlargement
163
When to treat ARVC?
> 1000 VPC/24h, vtach runs, RonT Early if homozygous for striatin mutation? Treatment: Decreases vpc and syncopal episodes Sotalol or mexiletene, sometimes need combo Therapeutic effect = 85 % reduction VPC number (due to daily variation) Fish oils decrease VPC? Not > variation... Lcarnitine might imp systolic function/prognosis Also standard cardiac
164
ARVC px?
If no vent dilation or systolic dysfunction, comparable to non-ARVC - live to around 11y
165
What is myocarditis?
Necrosis, degeneration, inflammation Physical/chemical/infectious May cause chamber dilation, arrhythmia, systolic dysfunction Protozoal/viral most common in dog Troponin often increased
166
Possible infectious causes of myocarditis?
Trypanosoma cruzi (serology, circulating trypomastigotes - tx with cysteine protease inhibitor? for heart effects, arrhythmia and RCHF) Leishmania (parasite in myocardium and assoc inflammation, AV block) Toxo/Neo Parvo (peracute, 3-8w puppies or < 1y DCM) West Nile (RTPCR, IHA, serology, virus isolation) Blastomyces (uncommon presentation and poor px) Borrelia burgdorferi
167
HCM in dogs?
HOCM in pointers, heritable
168
T/F: doberman DCM is caused by hypoT4?
False, no link
169
Difference between primary and secondary cardiomyopathies in cats?
Primary - confined to myocardium, genetic/non genetic/mixed | Secondary - myocardial involvement of systemic/multiorgan disorder
170
Prevalence of the different cardiomyopathies?
``` HCM 58 % RCM 21 % DCM 10 % UCM 10 % ARVC uncommon ```
171
Left ventricular moderator bands?
Might be incidental If dense network may have cardiac consequences - poss role in HOCM? More commonly in the outflow tract in HOCM than healthy or non obst HCM
172
Types of HCM?
Either diffuse concentric left vent hypertrophy (2/3) - which can be asymmetric IVS/LVFS or one segment (basal IVS or apex) OHCM - obstruction of LVOT often by protruding thickened basal IVS Papillary hypertrophy can cause systolic mid ventricular cavity obstruction and endocardial contact plaques Can get infarction LVFW Right ventricle can also be thickened. NB dilated stage with thin walls
173
Breeds and HCM types?
OHCM Persian/Chartreux (44 % cf 18 % other breeds) | 50 % Maine coone diffuse symmetric LVH
174
HCM histopath?
Myocardial fibre disarray, fibrosis, arteriosclerosis Inflammatory infiltrates in preclin
175
Signalment HCM?
Male DSH, DLH, BSH, Himalayan, sphinx 5-7y Maine coone/sphynx/ragdoll younger?
176
Genetic HCM?
Maine coone - myosin binding protein C sarcomeric gene (MyBPC3) auto dom but higher risk of HCM for homozygotes, incomplete penetrance hetero at middle age Ragdoll - MyBP3 (diff mutation). homozygotes worse px. Sphynx - auto dom incomplete penetrance
177
Cats pleural effusion?
Can be caused by LHS dz as visceral pleural veins drain to LA
178
What cardiac auscultation abnormalities are more common in symptomatic HCM cats?
Gallop and arrhythmia
179
Clinical predictors of cardiac death in HCM?
Arrhythmia, gallop, CHF, ATE, syncope. LA enlargement, severe LVH, decreased systolic function, decreased LA function, RV enlargement, regional wall hypokinesia, spontaneous contrast, restrictive diastolic filling pattern Ragdolls (homozygote) and Maine coone more poor px
180
Types of RCM?
Fibrosis in walls, fibrosis on walls, fibrosis between walls - myocardial/endomyocardial Same histopath cf HCM (sarcomere mutation?)
181
RCM signalment?
10y - older cf HCM Conflicting studies on sex DSH, Burmese, siamese, Persian, birman, maine coone
182
Clin signs RCM?
Almost all clinical at presentation, cf HCM
183
Px RCM?
Poor 200 d cf 1000 HCM
184
DCM histopath?
Myocytolysis, fibrosis, coronary arteriosclerosis, inflamm infiltrates
185
DCM signalment?
9y | Conflicting sex predilection
186
Clin signs DCM?
Usually symptomatic, often hypotensive
187
Px DCM?
Days, sl better (month) if add pimobendan tx to standard (taurine, furosemide, acei) Negative - hypothermia, FS < 20 %
188
What is striatin?
Located at intercalated disc cardiomyocytes, co localised with other desmosomal proteins involved in human ARVC
189
ARVC in cats?
< 5 % No genetic Histopath - diffuse/segmental RV wall thinning, aneurysm, RA enlargement Myocardial atrophy and fatty or fibrous tissue replacement Usually CHF at presentation but can be asymptomatic Poor px if overt - days/weeks survival
190
ARVC signalment cats?
7Y No breed/sex predilection Familial?
191
Taurine and feline myocardial disease?
Cats have low cysteine sulfinic acid decarboxylase so can't synthesise much taurine from cysteine Exclusively use taurine for bile acid conjugation (cf glycine) 25 % taurine deficient cats get myocardial failure (also retinal central degeneration, CNS, immune, repro) DCM - check taurine and retina (1/3 and may be sign of past taurine def) and diet hx (whole blood taurine better but affected by fasting) Diet - heat processing in canning, potassium depletion, acidification, rice brain/whole rice Difficult to diagnose so supplement if DCM (rapid improvement if taurine deficient, some persistent signs but better and aymptomatic)
192
UCM echo changes?
Segmental LVH, regional hypokinessia, marked LAE Could be form of HCM or RCM
193
Signalment UCM?
Female | 8y
194
Px UCM?
Better (900d, cf HCM 500, RCM 100, DCM 11)
195
What should be ruled out when considering primary cardiomyopathy in cats?
HT4, lymphoma in wall, myocarditis, muscular dystrophy, hypersomatotropism, aortic stenosis, hypertension, taunt, doxorubicin, sustained tachyarrhythmia
196
VHS in cats?
> 8 specific not sensitive, esp left dz Acute dyspnoea - > 9 highly specific
197
Significance of valentine heart?
Not spec for HCM or even cardiac disease, doesn't predict biatrial enlargement
198
What interferes with echo in cats?
Dehydration - increase wall thickness and decrease LV diameter Volume - increase LV diameter, fractional shortening and LA:Ao, with appearance of a murmur Less skilled echo overest wall thickness Breed - sphinx 5 or 5.5 in < or > 5kg, > 6 others
199
LA size in cats?
Prognostic and marker of chronicity 1.3 end diastole, 1.5 end systole
200
Biomarkers feline myocardial disease?
Troponin: cTNI and TNT predictor of death in HCM but low sens/spec, TNI more sens. No corr echo. TNI higher in cardiac dyspnoea cf non cardiac but overlap NTproBNP: 90 % accurate to distinguish cardiac resp signs 70 % sens/100 % sens to identify occult dz cf healthy if > 99. Corr LV thickness and LA:Ao.
201
Echo marker of decreased diastolic function?
Inversed E:A = relaxation pattern (<1 HCM), restrictive pattern (E:A increase > 2 with increased E decreased A)
202
How to classify evidence levels?
Level 1 - at least 1 PRCT Level 2 - at least one well designed clinical trial without randomisation, cohort/case controlled studies lab models, dramatic uncontrolled Level 3 - opinion , pathophys justification
203
Medication evidence in feline cardiac disease?
Beta blockers: atenolol - decrease HR/ increase diastole, decrease LVOTO, negative inotrope, decrease myocardial O2 demand which is antiarrhythmic Ivabradine - inhibit If current in SA node so negative chronotrope - level 1 evidence for imp diastolic function in HEALTHY cats Calcium channel blockers - negative chrono/inotrope, imp LV relaxation, coronary vasodilation, antiarrhythmic. Level 3 evidence to avoid dihydropyridine (amlodipine) because of excess vasodilation. Diltiazem (less potent negative inotrope/vasodilator cf verapamil) more commonly used. ACEi\aldosterone blocker - stop myocardial hypertrophy, reverse lesions, vasodilatory and imp diastolic in LVH animal models
204
Stage B feline cardiac dz management evidence?
80 % asymptomatic HCM die non cardiac dz Atenolol: no survival benefit (level 1 evidence), no decrease in biomarker Maine coone (level 2), may be deleterious as decreases LA function and flow velocity in left auricle of healthy cats (risk factors for ATE) 0 ? deleterious? Use in LVOTO or vent arrhythmia? Benazepril: level 1 for increase mitral E:A ratio cf diltiazem, but not sig Ramipril/spironolactone: no imp diastolic function Maine coone Spironolactone: facial dermatitis 1/3 @ 2.5m reversible when stop, dose 2mg/kg BID (level 1) Clopidogrel: no evidence
205
Stage C feline cardiac dz management evidence?
Furosemide, sedation, thoracocentesis, cage rest (level 3) Diltiazem: imp clin signs and imaging with 94 % survival at 6m (level 2) Benazepril: added to diltiazem, imp clin signs and LV (level 2) Enalapril: with furosemide, survival longer cf diltiazem or placebo or atenolol (920, 227, 235, 72d) - level 1 with no stat sig
206
Stage D feline cardiac dz management evidence?
``` Spironolactone (level 3) Hydrochlorthiazide added (level 3) Pimobendan - LV systolic dysfunction (level 2), not OHCM due to worsening/hypotension (level 3) ```
207
Other feline cardiac dz management evidence?
Taurine for DCM (level 1) Pimobendan DCM (level 2 as increased MST) ARVC - similar DCM, level 3 evidence
208
Breed for PPDH?
Weimeraner DLH, Main coone
209
ECG in PPDH?
Low voltage complexes | Shift electrical axis
210
What is cardiac tamponade?
Impairment of ventricular filling due to fluid accumulation in pericardial space, reducing SV and CO Diastolic collapse of right heart
211
What volume of pericardial fluid is required for cardiac tamponade?
Acute - 50 - 150 ml for 20 kg dog | Chronic - stretch allows for more fluid - can accommodate several hundred more litres
212
Clinical presentation of cardiac tamponade?
Acute - arterial hypotension due to decreased diastolic filling of left heart due to decreased right heart output Chronic - RCHF Increase in diastolic pressure req to cause leaking of systemic capillaries is lower than that required for pulmonary - so pulm oedema not common
213
Difference in neurohormonal activation pericardial effusion cf heart failure?
No ANP increase, limits natriuresis and contributes to volume overload - this is why chronic causes effusion
214
Changes in stroke volume during inspiration?
Neg intrathoracic pressure causes pooling in RHS - compliant - and decreased LV preload, RV output higher LV lower (hence increased HR on inspiration)
215
Pericardial effusion on inspiration?
Ventricular interdependence, increased right heart at expensive of left, so decreased LV output (pulsus paradoxus)
216
How many dogs with cardiac HSA have concurrent splenic?
30 %
217
Most common site of mesothelioma metastasis?
Intrathoracic LNs
218
Metastasis heart base thyroid gland carcinoma?
Pericardium
219
Idiopathic pericarditis aetiology?
Viral/immune mediated. Mononuclear inflamm/fibrosis target pericardial blood vessels ad lymphatics. Damaged blood vessels > bleeding. Chronic. 50 % don't recur. 50 % do days - years Sequel = restrictive
220
Infectious agents causing pericarditis?
Actinomyces, strep. bacteroides, pasteurella, coccidoises
221
XR for pericardial eff?
Not sens or spec
222
ECG pericardial effusion?
Electrical alternans Decreased QRS voltage - also fat pleural eff etc Ventricular arrhythmias
223
pH of pericardial fluid for aetiology?
Not reliable
224
Treatment of choice for recurrent idiopathic pericarditis?
Thoracotomy - 100 % survival MST not reached 3y Thoracocoscopic window - disease free interval 11.6m, MST 13m
225
Mesothelioma pericardial eff tx?
No sig diff surg vs window, approx 10m MST both Chemo might imp survival
226
Heart base mass and pericardial eff?
Partial pericardectomy MST 700d vs 42d w/out Chemo didn't help survival This is for aortic body tumours
227
Cardiac HSA?
Pericardectomy doesn't prolong survival. Resection and doxo prolongs survival. Doxo alone also. Neg px mass size and decreased platelet but NOT mets
228
What pericardial disease doesn't have pulsus paradoxus?
Constrictive pericarditis
229
D. immitis lifecycle in the dog?
Female worms produce L1, microfilariae, which circulate in the blood. Female mosquito feeds, L1 molts to L3 over 8 - 17 d - temp and Wolbachia pipientis dependent L3 infective, transmitted when mosquito feeds again L3 > L4 in subq/muscle/adipose 1 - 12 d L4 > S5 2 - 3 months post-infection Juvenile adult migrates to right pulmonary vessels, matures (females bigger than males) and mates. Life cycle completes in 180 - 210 days. Live mostly in caudal pulmonary vascular tree. Microfilaremia 6-7m post infection. Microfilaria persist 30m, adults 5 - 7 y
230
What determines severity of consequences of heart worm infection?
Burden of worms, duration of infection, interaction with immune system. Worm toxic substance/physical trauma/immune stim Dead worms severe inflamm reaction exercise increases pulm hypertension?
231
Occult heartworm disease?
Microfilaria immune mediated destruction in pulmonary circulation, amicrofilaraemia and eosinophilic pneumonitis
232
Cytological difference between D immitus and its imitator?
D. immitus - many, stationary, larger, straight body and tail with tapered head Dipetalonema reconditum - few, progressive motion, curved body blunt head curved tail, smaller
233
Test for D. immitus in dogs?
Mod. Knott more sens than direct smear. 10 - 20 % amicrofilaraemic, macrocyclic lactones do this Antigen test - only female adult - low worm burden false neg
234
Macrocyclic lactones and heartworm?
Milbemycins and avermectins Terminate L3/L4 larval development in 1st 2m infection Minimal adverse reaction microfilaraemic dogs. Some adulticidal. Many microfilariacidal Resistance reported Moxidectin imidacloprid heartworm/microfilaria, render females sterile, kill adults Ivermectin 3m reach back doxycycline synergistic
235
Adulticide therapy for heartworm?
Melarsomine, 90 % worm kill 70 % dogs cleared Split dose safer - 50 % worm kill 1st then 100 % 1 month later
236
Pro/con single dose/split dose protocol D. immitus?
Single - cheaper, don't have to exercise restrict so long, less melarsomine exposure (better if hepatorenal dz) Split - safer and more efficacious, better resolution proteinuria Doxycycline also reduces severity of lung lesions on worm kill
237
When to recheck antigen after adulticide tx in heartworm?
8m
238
What dogs are most likely to get heartworm naval syndrome?
Males
239
Differences in feline heartworm?
More resistant, often worms don't mature, longer prepatent period, get pulmonary dz even if worms don't mature. 50 % exposed get heartworm assoc resp dz Pulmonary arterial response more marked (pulmonary interstitial macrophages) even though worm burden lower Embolisation more significant as cats less pulm collaterals Wollbachia might mediate bronchoconstriction
240
Cytokines in feline heartworm dz?
PGE2 HARD, TXB2/LTB4 mature HW
241
Differences between HARD and mature heartworm infection in cats?
HARD - clin signs 3m, due to immature heart worms in pulm arteries, resp signs, antigen neg AB pos filaria neg, bronchointerstitial with normal echo Mature - > 7m, pulm and cardiac, neuro, emesis, more severe resp, Ag pos/neg, AB pos, microfilaria sometimes, variable XR with vessel changes, echo sometimes abnormal
242
Difference between arterial thrombosis and. thromboembolism?
AT: made at site, shear stress and narrowed vessel ATE: vessel normal, from diff site, due to stagnant flow ATE common AT not Venous > arterial uncommon (unless ASD) - exception is pulm venous emboli eg d/t neoplasia
243
Coag changes in canine thrombosis
Low - AT, protein C High - I, II, V, VII - X, XII Platelet hypersensitivity
244
Pathophys ATE?
In aorta, acute and release vasoactive substances from activates platelets causes vasoconstriction which inhibits development of collateral supply and get ischaemic neuromyopathy NB serotonin
245
Second most common vascular obstruction in feline cardiac dz?
Right subclavian
246
Mechanism of heparin?
AT mediated II, X-XII, and thrombin catalysed V and VIII, inhibit thrombin platelet aggregation and vWF
247
Reperfusion injury?
Metabolic acidosis and hyperkalaemia 40 - 70 % cats undergoing thrombolytic tx Thrombolytics most dangerous aortic, less so cerebral/splanchnic/renal?
248
Thrombolytic tx?
Streptokinase - activate plasminogen - one study all cats died - another 50 % return femoral pulses 24h, motor function 30 %, single limb better (80 % motor function), bleeding 1/4 and severe, 50 % reperf - dogs good response small number cases Urokinase - more fibrin specific eg just fibrin bound plasminogen - LMW molecules bind greater affinity to lysine-plasminogen form which accumulate in thrombi - cats 50 % motor function 27 % pulse no bleeding, 1/4 reperf - dogs all dead tPA: case reports, works in some
249
How to improve collateral flow thromboembolism?
Aspirin (TXA2 inh, vasodilation) Clopidogrel inh serotonin release
250
Negative px indicator cat ATE?
Hypothermia two limbs bradycardia absent motor function Around 30 % survival. MST 50 - 350d.
251
Feline thrombosis prevention?
Suggested if LA:Ao > 2 or spontaneous contrast If have antithrombotic added on initial event, 17 - 75 % happen again, 25 - 50 % in a year FAT CAT - clopidogrel decreases recurrence and increases time to recurrence versus aspirin - 443 vs 192 and reduced likelihood of recurrence/cardiac death = 346/128 d
252
Aspirin mechanism of action?
Inhibits secondary platelet aggregation, reduce TXA2 and prostacyclin production (latter endothelium compensates for in vivo) Lower dose no sig diff thromboembolic recurrence but less GI Survival increased in IMHA dogs
253
Clopidogrel mechanism of action?
ADP2Y12 blocker Primary and secondary platelet aggregation Inhibit ADP induced GPIIb/IIIa conformational change so no vWF/fibrinogen binding Impairs platelet release reaction - decrease vasoconstriction/proaggregate serotonin/ADP Hepatic biotransformation p450 No bleeding complications reported.
254
LMW heparin?
Less II inhibition so aPTT normal Similar recurrence/MST in cats cf warfarin with ATE - warfarin study 42 - 53 % and MST 471 d (vs 210d) - lots of bleeding Infrequent bleeding LMW hep
255
Lymphatic ducts?
Thoracic duct drains everything apart from that drained by the right lymphatic duct which drains the right heart/neck and right forelimb